Anthera Pharmaceuticals Inc. hopes to net $47 million by selling more than 6.6 million shares at $7.50 each.
The Hayward developer of cardiovascular and autoimmune disease drugs (NASDAQ: ANTH) said the offering is expected to close next week. The final figure could swell to $54 million if underwriters exercise an over-allotment option.
No comments:
Post a Comment